COMP <GO>
KMTS vs LMAT // DIVIDEND YIELD & FCF PAYOUT SAFETY
Kestra Medical Technologies Ltd. (NASDAQ) VS. LeMaitre Vascular Inc. (NASDAQ) • 15-METRIC TALLY: KMTS 3
— LMAT 8
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: LMAT
LAST: $30.61 (+2.48%) • MKT CAP: $1.82B
dividend-safety
0.00%
LAST: $85.27 (+2.90%) • MKT CAP: $1.95B
dividend-safety
0.93%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KMTS VS. LMAT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KMTS | LMAT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.40% | 71.50% | -20.10 | LMAT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 14.70% | -49.70 | LMAT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 28.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.40% | 4.17% | -10.57 | LMAT | /fcf-yield <GO> |
| Operating Margin | -60.00% | 27.20% | -87.20 | LMAT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 23.10% | -83.10 | LMAT | /net-margins <GO> |
| Revenue Growth (YoY) | 59.00% | 13.50% | +45.50 | KMTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.93% | -0.93 | LMAT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.65 | 7.30 | +2.35 | KMTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | LMAT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.5 | 45.4 | +12.17 | KMTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 28.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.82B | $1.95B | -$126.9M | LMAT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KMTS REV | LMAT REV | KMTS GROSS % | LMAT GROSS % | KMTS FCF | LMAT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $95.1M | $249.6M | 51.4% | 71.5% | -$116.6M | $81.3M |
| FY 2024 | $59.8M | $219.9M | 40.5% | 68.6% | -$100.5M | $44.1M |
| FY 2023 | $27.8M | $193.5M | — | — | -$72.2M | $36.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KMTS // BETA —
LMAT // BETA —